Sana Biotechnology
Sana Biotechnology is a biotechnology company focused on engineered cells as medicines.
Last updated September 1, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Sana Biotechnology is a biotechnology company that aims to lead the way in engineered cells as medicines. The company is advancing innovative drug candidates with the goal of changing the possible for patients in diseases like diabetes, B-cell cancers, and B-cell related autoimmune disorders.
History
Sana Biotechnology is a biotechnology company. It was founded with the long view of bringing together great people and the best technologies to deliver on the challenging promise of engineered cells as medicines. The company has three aspirations: repair and control genes in any cell, replace any cell in the body, and tear down barriers to accessing therapies.
Recent events
Reported
Sana, IASO Bio and Innovent announce BCMA CAR licensing agreement[4]
Sana Biotechnology, IASO Bio and Innovent announced a strategic collaboration and non-exclusive license under which IASO Bio and Innovent granted Sana commercial rights to their clinically validated fully human BCMA CAR structure for specified in vivo gene therapy and ex vivo hypoimmune cell therapy product development. IASO Bio and Innovent are eligible for an upfront payment, development and regulatory milestones, and sales royalties.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/sana-biotechnology · Editorial policy · How profiles are compiled